79
8.1. Goals of Therapy With Rhythm Control
COR LOE
Recommendations
1 B-R 1. In patients with reduced LV function and persistent (or high
burden) AF, a trial of rhythm control should be recommended
to evaluate whether AF is contributing to the reduced LV
function.
2a B-R 2. In patients with symptomatic AF, rhythm control can be
useful to improve symptoms.
2a B-R 3. In patients with a recent diagnosis of AF (<1 year), rhythm
control can be useful to reduce hospitalizations, stroke, and
mortality.
2a B-R 4. In patients with AF and HF, rhythm control can be useful
for improving symptoms and improving outcomes, such as
mortality and hospitalizations for HF and ischemia.
2a B-NR 5. In patients with AF, rhythm-control strategies can be useful to
reduce the likelihood of AF progression.
2b C-LD 6. In patients with AF where symptoms associated with AF
are uncertain, a trial of rhythm control (eg , cardioversion or
pharmacological therapy) may be useful to determine what if
any symptoms are attributable to AF.
2b B-NR 7. In patients with AF, rhythm-control strategies may be useful
to reduce the likelihood of development of dementia or
worsening cardiac structural abnormalities.
8. Rhythm Control
